Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service kyphoplasty & vertebroplasty cases in North Dakota: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 8% on average (184 state-years, 2020–2024): read it as a direction with a margin.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 3 | 157 | 20% |
| 2020 | 1 | 137 | 22% |
| 2021 | 1 | 117 | 25% |
| 2022 | 2 | 169 | 29% |
| 2023 | 2 | 128 | 34% |
| 2024 | 4 | 184 | 37% |
| 2025 from claims | – | 173 140–203 | 39% |
| 2026 forecast | – | 183 143–230 | 38% |
| 2027 forecast | – | 191 141–252 | 39% |
| 2028 forecast | – | 198 140–274 | 40% |
| 2029 forecast | – | 206 140–296 | 41% |
| 2030 forecast | – | 214 140–318 | 41% |
Vertebral compression fracture augmentation; IR, pain, spine surgeons. Professional codes (what the surgeon bills): CPT 22513, 22514, 22510, 22511.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 100% of the cases CMS names in North Dakota; 3 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 100% hospital outpatient.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Illinois | 22 | 1,781−6.9%/yr | −6.9%/yr | 1.3 | 16% | 1,860 in 2030+0.7%/yr |
| Ohio | 15 | 1,537−7.3%/yr | −7.3%/yr | 1.4 | 1% | 1,360 in 2030−2.1%/yr |
| Missouri | 13 | 1,235−7.5%/yr | −7.5%/yr | 2.0 | 5% | 1,060 in 2030−2.5%/yr |
| Michigan | 11 | 1,216−8.7%/yr | −8.7%/yr | 1.4 | 12% | 1,000 in 2030−3.2%/yr |
| Indiana | 13 | 1,180−9.3%/yr | −9.3%/yr | 1.6 | 19% | 1,300 in 2030+1.7%/yr |
| Kansas | 15 | 1,030−5.7%/yr | −5.7%/yr | 2.5 | 11% | 920 in 2030−1.8%/yr |
| Wisconsin | 5 | 577−4.4%/yr | −4.4%/yr | 1.0 | 12% | 650 in 2030+2%/yr |
| Nebraska | 6 | 473−8.9%/yr | −8.9%/yr | 1.8 | 16% | 510 in 2030+1.3%/yr |
| Minnesota | 1 | 310−5.8%/yr | −5.8%/yr | 0.7 | 8% | 290 in 2030−1.1%/yr |
| Iowa | 2 | 213−11%/yr | −11%/yr | 0.5 | 0% | 130 in 2030−7.9%/yr |
| South Dakota | 1 | 100−11%/yr | −11%/yr | 0.8 | 0% | 110 in 2030+1.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 9 | 384−6.4%/yr | −6.4%/yr | 3.81.2× | 13% | 320 in 2030−3.1%/yr |
| Lumbar fusion | 7 | 286+1%/yr | +1%/yr | 2.81.0× | 0% | 250 in 2030−2.3%/yr |
| Cervical fusion & disc arthroplasty | 3 | 152−5.1%/yr | −5.1%/yr | 1.51.1× | 0% | 160 in 2030+0.6%/yr |
Kyphoplasty & vertebroplasty in every state, and its device makers · Every procedure market in North Dakota · Every state · Compare with Illinois
VB Spine leads with 73% of company spending on these surgeons in 2025, −6 pts on 2024.
In 2025, 2 companies reported engagement with North Dakota’s surgeons worth $340 in consulting, speaking, meals and travel tied to these products, about $85 per surgeon billing it. Royalties are left out.
FDA, last 12 months: 1 clearance or approval in the category.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.